Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

3.320
+0.0100.30%
Volume:82.32M
Turnover:272.59M
Market Cap:62.32B
PE:24.59
High:3.370
Open:3.340
Low:3.280
Close:3.310
Loading ...

Sino Biopharmaceutical's Cancer Drug Shows Positive Results in Clinical Trials

MT Newswires Live
·
19 Dec 2024

Sino Biopharmaceutical - Permission Obtained to Submit Marketing Application for Indication of Benmelstobart Injection, Others From Nmpa

THOMSON REUTERS
·
19 Dec 2024

Sino Biopharmaceutical Gets China Nod to Market Breast Cancer Drug

MT Newswires Live
·
11 Dec 2024

Sino Biopharmaceutical - Approval for Marketing of Eribulin Mesilate Injection From Nmpa China

THOMSON REUTERS
·
11 Dec 2024

Is Sino Biopharmaceutical (HKG:1177) A Risky Investment?

Simply Wall St.
·
08 Dec 2024

Sino Biopharmaceutical Enters Global Collaboration Contract for Asthma Drug

MT Newswires Live
·
05 Dec 2024

Sino Biopharmaceutical - Agreement for Jointly Developed "Bsi-045B (Tqc2731)", an Anti-Tslp Monoclonal Antibody

THOMSON REUTERS
·
05 Dec 2024

Sino Biopharmaceutical - Global Collaboration Agreement With Biosion and Aclaris Therapeutics

THOMSON REUTERS
·
05 Dec 2024

Sino Biopharmaceutical Gets Chinese Regulator's Marketing Approval for Endometrial Cancer Drug

MT Newswires Live
·
27 Nov 2024

BRIEF-Sino Biopharmaceutical Receives Approval For Marketing Benmelstobart Injection In Combination With Anlotinib Hydrochloride Capsule

Reuters
·
27 Nov 2024

Sino Biopharmaceutical - Approval for Marketing of Benmelstobart Injection in Combination With Anlotinib Hydrochloride Capsule by Nmpa China

THOMSON REUTERS
·
27 Nov 2024

Sino Biopharmaceutical Submits New Indication Application for Liver Cancer Drug Combo

MT Newswires Live
·
21 Nov 2024

Sino Biopharmaceutical - Submitted a New Indication Application for Marketing to Cde for Anlotinib Hydrochloride Capsule

THOMSON REUTERS
·
21 Nov 2024

Sino Biopharm Injects 142 Million Yuan into LaNova Medicines

MT Newswires Live
·
20 Nov 2024

Greater China Stocks Close Mixed; Shanghai Leads Gainers

Dow Jones
·
20 Nov 2024

BUZZ-Sino Biopharmaceutical rises most in nearly 5 weeks on LaNova deal

Reuters
·
20 Nov 2024